SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria, PLoS ONE, vol.339, issue.1, p.1474, 2008. ,
DOI : 10.1371/journal.pone.0001474.s002
Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission, New England Journal of Medicine, vol.359, issue.5, pp.359463-472, 2008. ,
DOI : 10.1056/NEJMoa0707957
Early events in vaginal HIV transmission: implications in microbicide development, Future Virology, vol.4, issue.3, pp.259-269, 2009. ,
DOI : 10.2217/fvl.09.10
Interaction of Mannose-Binding Lectin with HIV Type 1 Is Sufficient for Virus Opsonization But Not Neutralization, AIDS Research and Human Retroviruses, vol.20, issue.3, pp.327-335, 2004. ,
DOI : 10.1089/088922204322996563
Sexual Transmission of HIV, New England Journal of Medicine, vol.336, issue.15, pp.1072-1078, 1997. ,
DOI : 10.1056/NEJM199704103361507
Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments, Journal of clinical microbiology, vol.38, issue.4, pp.1414-1418, 2000. ,
Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides, BMC Infectious Diseases, vol.7, issue.1, p.150, 2006. ,
DOI : 10.1042/bj2360097
Role of complement in the control of HIV dynamics and pathogenesis, Vaccine, vol.21, issue.2, pp.77-82, 2003. ,
DOI : 10.1016/S0264-410X(03)00203-2
Quantification of C3 and C4 in Infertile Men with Antisperm Antibody in Their Seminal Plasma, American Journal of Reproductive Immunology, vol.22, issue.1, pp.330-336, 1999. ,
DOI : 10.1111/j.1600-0897.1999.tb00446.x
Complement???HIV interactions during all steps of viral pathogenesis, Vaccine, vol.26, issue.24, pp.3046-3054, 2008. ,
DOI : 10.1016/j.vaccine.2007.12.003
The Complement System in Human Reproduction, American Journal of Reproductive Immunology, vol.173, issue.3-4, pp.3-4145, 1992. ,
DOI : 10.1111/j.1600-0897.1992.tb00742.x
Opsonization of HIV-1 by Semen Complement Enhances Infection of Human Epithelial Cells, The Journal of Immunology, vol.169, issue.6, pp.3301-3306, 2002. ,
DOI : 10.4049/jimmunol.169.6.3301
Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner, The Journal of Immunology, vol.178, issue.2, pp.1086-1095, 2007. ,
DOI : 10.4049/jimmunol.178.2.1086
Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies, J Immunol, issue.8, pp.1775540-5549, 2006. ,
Compans RW: A polarized human endometrial cell line that binds and transports polymeric IgA, In vitro cellular & developmental biology, issue.3, pp.31196-206, 1995. ,
Related mannose-specific lectins from different species of the family Amaryllidaceae, Physiologia Plantarum, vol.85, issue.1, pp.52-57, 1988. ,
DOI : 10.1016/0014-5793(87)80129-1
Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation., Antimicrobial Agents and Chemotherapy, vol.34, issue.1, pp.134-138, 1990. ,
DOI : 10.1128/AAC.34.1.134
The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type??1, BioMetals, vol.17, issue.3, pp.291-294, 2004. ,
DOI : 10.1023/B:BIOM.0000027707.82911.be
CADA, a Potential Anti-HIV Microbicide that Specifically Targets the Cellular CD4 Receptor, Current HIV Research, vol.6, issue.3, pp.246-256, 2008. ,
DOI : 10.2174/157016208784324958
Soluble CD16 Inhibits CR3 (CD11b/CD18)-Mediated Infection of Monocytes/Macrophages by Opsonized Primary R5 HIV-1, The Journal of Immunology, vol.166, issue.5, pp.3377-3383, 2001. ,
DOI : 10.4049/jimmunol.166.5.3377
Active and Selective Transcytosis of Cell-Free Human Immunodeficiency Virus through a Tight Polarized Monolayer of Human Endometrial Cells, Journal of Virology, vol.75, issue.11, pp.755370-5374, 2001. ,
DOI : 10.1128/JVI.75.11.5370-5374.2001
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Molecular immunology, pp.12-13855, 1997. ,
Complement enhancement of HIV infection is mediated by complement receptors, Immunopharmacology, vol.25, issue.2, pp.87-93, 1993. ,
DOI : 10.1016/0162-3109(93)90012-F
HIV and human complement: inefficient virolysis and effective adherence, Immunology Letters, vol.97, issue.2, pp.209-214, 2005. ,
DOI : 10.1016/j.imlet.2004.11.007
HIV Glycoprotein 41 and Complement Factor H Interact with Each Other and Share Functional as Well as Antigenic Homology, AIDS Research and Human Retroviruses, vol.11, issue.8, pp.11971-980, 1995. ,
DOI : 10.1089/aid.1995.11.971
Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59., Journal of Clinical Investigation, vol.96, issue.3, pp.961520-1526, 1995. ,
DOI : 10.1172/JCI118190
Enhancement of Complement-Mediated Lysis by a Peptide Derived from SCR 13 of Complement Factor H, Immunobiology, vol.203, issue.4, pp.670-686, 2001. ,
DOI : 10.1016/S0171-2985(01)80016-4
Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55) The Journal of experimental medicine, pp.307-310, 1996. ,
Mechanisms of Resistance of HIV-1 Primary Isolates to Complement-Mediated Lysis, Virology, vol.246, issue.2, pp.370-378, 1998. ,
DOI : 10.1006/viro.1998.9205
Microbicides: a new approach to preventing HIV and other sexually transmitted infections, Nature Reviews Drug Discovery, vol.62, issue.12, pp.977-985, 2002. ,
DOI : 10.1038/nrd959
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy, Nature Reviews Microbiology, vol.33, issue.8, pp.583-597, 2007. ,
DOI : 10.1038/nrmicro1707
Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection, Antimicrobial Agents and Chemotherapy, vol.48, issue.10, pp.483858-3870, 2004. ,
DOI : 10.1128/AAC.48.10.3858-3870.2004
R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: Implication for mechanisms of sexual transmission, Virology, vol.358, issue.1, pp.55-68, 2007. ,
DOI : 10.1016/j.virol.2006.07.029
Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. The Journal of biological chemistry, pp.21353-21357, 2005. ,
Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation, AIDS, vol.5, issue.3, pp.269-274, 1991. ,
DOI : 10.1097/00002030-199103000-00004
DC-SIGN, a Dendritic Cell???Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells, Cell, vol.100, issue.5, pp.587-597, 2000. ,
DOI : 10.1016/S0092-8674(00)80694-7
T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins, Immunology, vol.164, issue.4, pp.508-518, 2008. ,
DOI : 10.1128/JVI.78.20.10848-10855.2004
>IFNgamma-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells, Journal of leukocyte biology, issue.3, pp.81642-653, 2007. ,
Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells, European Journal of Biochemistry, vol.84, issue.2, pp.271303-317, 2004. ,
DOI : 10.1023/A:1026205603217
URL : https://hal.archives-ouvertes.fr/hal-00104916
The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. The Journal of biological chemistry, pp.27720877-20886, 2002. ,
Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?, Nature Reviews Microbiology, vol.11, issue.4, pp.312-317, 2006. ,
DOI : 10.1038/nrmicro1387
Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization AIDS Research and Therapy, p.16, 2010. ,